Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Cadila Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011797
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cadila Pharmaceuticals Ltd (Cadila Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The company’s products include active pharmaceutical ingredients (API) and pharmaceutical formulations. Its business includes contract research operation, contract manufacturing, herbal and agro divison. Cadila Pharmaceuticals products are used in the therapeutic areas of gastrointestinal, cardiovascular, anti-infectives and antibiotics, analgesics, haematinics, respiratory agents, immunologicals, oncology and antidiabetics, among others. The company’s products are in the form of capsules, tablets, orals, soft and hard gelatin capsules, and liquids. It has operations in Kenya, Nigeria, Ethiopia, the UK, Russia, the US, Sweden and Japan. Cadila Pharmaceuticals is headquartered in Ahmedabad, Gujarat, India.

Cadila Pharmaceuticals Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cadila Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Aplagon Enters into Agreement with Cadila Pharma Sweden 11
Oncology Venture Enters into Co-Development Agreement with Cadila Pharma 12
Lipidor Enters into Agreement with Cadila Pharma 13
Axelar Enters into Co-Development Agreement with Cadila Pharma 14
Cadila Pharma Enters into Agreement with Respiratorius 15
NovaSAID Enters Into Co-Development Agreement With Cadila Pharma 16
Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 17
Licensing Agreements 18
Cadila Pharma and Altus Formulation Enter into Agreement 18
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 19
Cadila Pharma Enters Into Licensing Agreement With Helperby Therapeutics 20
Cadila Pharmaceuticals Ltd – Key Competitors 21
Cadila Pharmaceuticals Ltd – Key Employees 22
Cadila Pharmaceuticals Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Legal and Regulatory 25
Sep 02, 2016: Cadila Healthcare Receives Establishment Inspection Report For Ahmedabad 25
Aug 16, 2016: Cadila Healthcare provides Operational Update 26
Aug 16, 2016: Cadila Healthcare Receives Establishment Inspection Report For Changodar Facility 27
Other Significant Developments 28
Mar 22, 2016: Cadila Healthcare: Corporate Announcement 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cadila Pharmaceuticals Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Cadila Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aplagon Enters into Agreement with Cadila Pharma Sweden 11
Oncology Venture Enters into Co-Development Agreement with Cadila Pharma 12
Lipidor Enters into Agreement with Cadila Pharma 13
Axelar Enters into Co-Development Agreement with Cadila Pharma 14
Cadila Pharma Enters into Agreement with Respiratorius 15
NovaSAID Enters Into Co-Development Agreement With Cadila Pharma 16
Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 17
Cadila Pharma and Altus Formulation Enter into Agreement 18
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 19
Cadila Pharma Enters Into Licensing Agreement With Helperby Therapeutics 20
Cadila Pharmaceuticals Ltd, Key Competitors 21
Cadila Pharmaceuticals Ltd, Key Employees 22
Cadila Pharmaceuticals Ltd, Other Locations 23
Cadila Pharmaceuticals Ltd, Subsidiaries 23
Cadila Pharmaceuticals Ltd, Joint Venture 24

★海外企業調査レポート[Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Diamondback Energy Inc (FANG):企業の財務・戦略的SWOT分析
    Summary Diamondback Energy Inc (Diamondback Energy) operates as an oil and gas company that offers exploration and development programs. The company acquires, develops, explores and exploits unconventional, onshore oil and natural gas reserves in Permian Basin in West Texas. It develops the reserves …
  • Industriens Pensionsforsikring AS:電力:M&Aディール及び事業提携情報
    Summary Industriens Pensionsforsikring AS (Industriens Pensionsforsikring) is an insurance service provider. The company offers member pension insurance and company pension insurance products. Its member pension insurance covers critical illness, loss of earning capacity, death, healthcare, insuranc …
  • CDI Corp.:企業の戦略的SWOT分析
    CDI Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Hyundai Engineering & Construction Co Ltd (000720):企業の財務・戦略的SWOT分析
    Hyundai Engineering & Construction Co Ltd (000720) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • juwi AG:電力:M&Aディール及び事業提携情報
    Summary juwi AG (juwi) a subsidiary of MVV Energie AG, is a renewable energy company that offers project development and engineering procurement and construction services; and products and solutions for the energy turnaround. It offers whole-scale project development services for the planning and co …
  • Lietuvos Energija UAB:電力:M&Aディール及び事業提携情報
    Summary Lietuvos Energija UAB (Lietuvos Energija) is a state-owned utility. The utility’s activities include power and heat distribution and supply; natural gas trade and distribution; construction and maintenance of power plants and grid; development of energy infrastructure and green energy; and d …
  • Synedgen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Synedgen Inc (Synedgen) is a biotechnology company that focuses on the discovery and development of polysaccharide-based drugs. The company’s pipeline products include SYGN 113; SYGN 115; SYGN 146; SYGN 303; SYGN 313 and SYGN 399 among others. Synedgen develops products for the treatment of …
  • FibroGen Inc (FGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary FibroGen Inc (FibroGen) is a biotechnology company that discovers, develops and commercializes new therapeutics. The company’s pipeline product portfolio includes FG-4592, an oral small molecule inhibitor of HIF prolyl hydroxylases that is used for the treatment of anemia in chronic kidney d …
  • Puracap Pharmaceutical LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Puracap Pharmaceutical LLC (PuraCap) is a drug development company that offers prescription generics and OTC products. The company provides over the counter soft gels and oral solid dosage healthcare products for upper respiratory, pain relief, cough and cold, sleep aid, gastrointestinal, an …
  • Nagacorp Ltd:戦略・SWOT・企業財務分析
    Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report Summary Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • CytomX Therapeutics Inc (CTMX):製薬・医療:M&Aディール及び事業提携情報
    Summary CytomX Therapeutics Inc (CytomX) is a clinical-stage biopharmaceutical company which develops novel therapeutic antibodies and Probody therapeutics for the treatment of cancer. The company’s leading product candidates include CX-072, CX-2009, BMS-986249, CX-2029, CX-188, probody drug conjuga …
  • High Peak Royalties Limited (HPR):企業の財務・戦略的SWOT分析
    High Peak Royalties Limited (HPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • University of Pennsylvania:医療機器:M&Aディール及び事業提携情報
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • Hamamatsu Photonics KK (6965):企業の財務・戦略的SWOT分析
    Hamamatsu Photonics KK (6965) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • BOE Technology Group Co Ltd:企業の戦略・SWOT・財務情報
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Breg Inc-医療機器分野:企業M&A・提携分析
    Summary Breg Inc (Breg) is a medical device company that manufactures and distributes cold therapy products. The company offers products, which include cold therapy products, hip braces, elbow or wrist braces, knee braces, shoulder braces, spine braces, ankle braces, home therapy kits, and others. I …
  • Globe Specialty Metals, Inc.:企業の戦略・SWOT・財務分析
    Globe Specialty Metals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Globe Specialty Metals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • China Telecom Corporation Limited:企業の戦略・SWOT・財務情報
    China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • W. L. Gore & Associates Inc:企業の戦略的SWOT分析
    W. L. Gore & Associates Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆